1
|
Nakajima S, Kittaka N, Taniguchi A, Kanaoka H, Oyama Y, Seto Y, Soma A, Okuno J, Kusama H, Matsui S, Watanabe N, Yoshida K, Honma K, Kurita T, Nakayama T. [A Case of Chronic Expanding Hematoma of the Lower Abdomen after Reconstruction of Deep Inferior Epigastric Perforator Flap for Breast Cancer]. Gan To Kagaku Ryoho 2023; 50:1680-1682. [PMID: 38303171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2024]
Abstract
A 49-year-old woman who had surgery for left breast cancer and subsequently underwent a two-stage deep inferior epigastric perforator(DIEP)flap reconstruction. One month postoperatively, she became aware of abdominal distention and visited a local hospital. CT scan revealed subcutaneous fluid accumulation with capsular formation in the lower abdomen. Imaging findings and physical examination showed no abdominal wall scar hernia. After multiple puncture aspirations, fluid accumulation was observed again, and the possibility of a chronic expanding hematoma was considered. Later, hematoma removal, including the capsules, was performed; pathological findings showed no evidence of malignancy. No fluid retention was observed postoperatively. In cases where imaging evaluation reveals hematoma formation with capsules, hematoma removal, including the capsules, should be performed to avert the possibility of a chronic expanding hematoma.
Collapse
Affiliation(s)
- Satomi Nakajima
- Dept. of Breast and Endocrine Surgery, Osaka International Cancer Institute
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Kusama H, Kittaka N, Soma A, Taniguchi A, Kanaoka H, Nakajima S, Oyama Y, Seto Y, Okuno J, Watanabe N, Matsui S, Nishio M, Fujisawa F, Honma K, Tamaki Y, Nakayama T. Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer. Breast Cancer 2023; 30:1085-1093. [PMID: 37782377 DOI: 10.1007/s12282-023-01504-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2023] [Accepted: 09/09/2023] [Indexed: 10/03/2023]
Abstract
BACKGROUND Tumor-infiltrating lymphocytes (TILs) predict response to neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) patients. However, the TIL level can be determined at a few facilities. By contrast, neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are easily and objectively determined from the results of full blood counts. We conducted a retrospective study to investigate whether TILs, NLR, and PLR predict NAC efficacy and whether NLR and PLR could be surrogate markers for TILs in TNBC. METHODS Of the 266 patients diagnosed with TNBC between 2013 and 2019, 66 who underwent radical surgery after sequential administration of anthracycline and taxane as NAC were included in the study. TILs, NLR, and PLR were evaluated as predictors of pathologic complete response (pCR) using cutoff values determined from receiver operating characteristic curves. RESULTS The cutoff values of TILs, NLR, and PLR were 20%, 2.6, and 180, respectively. High TIL level was associated with low NLR (P = 0.01) and low PLR (P = 0.01). High TIL level (odds ratio [OR] 4.28 [95% CI 1.40-13.1]; P = 0.01), low NLR (OR 5.51 [95% CI 1.60-18.9]; P = 0.01), and low PLR (OR 3.29 [95% CI 1.13-9.57]; P = 0.03) were associated with pCR. Low NLR predicted pCR independently (OR 6.59 [95% CI 1.45-30.0]; P = 0.01). CONCLUSIONS TILs, NLR, and PLR predicted NAC efficacy against TNBC. TIL level was associated with NLR and PLR. NLR was an independent predictive factor and may be a useful surrogate marker for TILs when predicting pCR.
Collapse
Affiliation(s)
- Hiroki Kusama
- Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-Ku, Osaka, 541-8567, Japan
| | - Nobuyoshi Kittaka
- Department of Breast Surgery, Osaka Rosai Hospital, 1179-3 Nagasone-Cho Kita-Ku Sakai-Shi, Osaka, 541-8567, Japan
| | - Ai Soma
- Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-Ku, Osaka, 541-8567, Japan
| | - Azusa Taniguchi
- Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-Ku, Osaka, 541-8567, Japan
| | - Haruka Kanaoka
- Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-Ku, Osaka, 541-8567, Japan
| | - Satomi Nakajima
- Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-Ku, Osaka, 541-8567, Japan
| | - Yuri Oyama
- Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-Ku, Osaka, 541-8567, Japan
| | - Yukiko Seto
- Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-Ku, Osaka, 541-8567, Japan
| | - Jun Okuno
- Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-Ku, Osaka, 541-8567, Japan
| | - Noriyuki Watanabe
- Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-Ku, Osaka, 541-8567, Japan
| | - Saki Matsui
- Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-Ku, Osaka, 541-8567, Japan
| | - Minako Nishio
- Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Fumie Fujisawa
- Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Keiichiro Honma
- Department of Pathology, Osaka International Cancer Institute, Osaka, Japan
| | - Yasuhiro Tamaki
- Department of Breast and Endocrine Surgery, Kaizuka City Hospital, 3-10-20 Hori Kaizuka-Shi, Osaka, 597-0015, Japan
| | - Takahiro Nakayama
- Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-Ku, Osaka, 541-8567, Japan.
| |
Collapse
|
3
|
Atake Y, Nagahashi M, Kanaoka H, Hattori A, Bun A, Fukui R, Ozawa H, Fujimoto Y, Higuchi T, Imamura M, Murase K, Takatsuka Y, Kashima M, Okada C, Kinjo C, Miyata M, Miyazaki A, Ueda M, Tsubamoto H, Sawai H, Miyoshi Y. Abstract P5-12-02: Germline variants detected by next-generation sequencing-based multigene panel testing in patients with suspected hereditary breast cancer at a University Hospital in Japan. Cancer Res 2023. [DOI: 10.1158/1538-7445.sabcs22-p5-12-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/06/2023]
Abstract
Abstract
Background: The usefulness of prophylactic surgery and surveillance for hereditary breast cancer has been demonstrated, and germline testing for BRCA1 and BRCA2 had been covered by insurance since 2020 in Japan. In addition to BRCA1 and BRCA2, several other genes are also associated with an increased risk of developing breast cancer, such as PALB2, ATM, BARD1, CHEK2, PTEN, and TP53. Next-generation sequencing-enabled multigene panel tensing provides information about these gene variants at the same time, and at a low cost. Although germline testing of BRCA1 and BRCA2 has become widespread in Japan, multi-panel gene testing for germline variants has been conducted only in a limited number of facilities, partly due to the difficulty associated with dealing with the gene variant information obtained from the test. The aim of this study was to clarify the current status of multigene panel testing in our institute, and reveal the characteristics of the variants detected in patients with, or predisposed to, hereditary breast cancer. Methods: This retrospective study included 37 individuals who underwent next-generation sequencing-based multigene panel testing in order to investigate any inherited genetic variants due to a suspicion of hereditary breast cancer. Eighteen patients had a diagnosis of breast cancer with a family history of breast and/or ovarian cancer, nine patients had a diagnosis of breast cancer without family history of breast or ovarian cancer, and 10 patients had a family history of breast cancer but had not developed breast cancer themselves. Results: Utilizing mutigene panel testing, at least one alteration was found in 24 genes, and a total of 39 variants were found in the 37 patients. Of these 37 patients, nine (24.3%) had a pathogenic/likely pathogenic variant with or without other variants of uncertain significance (VUS), 15 (40.5%) had VUS, and 13 (35.1%) had negative genetic test results. Among the nine patients with pathogenic/likely pathogenic variants, seven had variants in either BRCA1 or BRCA2 (one BRCA1 pathogenic variant, five BRCA2 pathogenic variants, and one BRCA2 likely pathogenic variant), while the remaining positive results were attributed to other genes (one MLH1 pathogenic variant, and one SDHB pathogenic variant). VUS included BRCA1 and BRCA2, as well as other breast cancer-associated genes, such as ATM (n=2), CDH1 (n=2), NF1 (n=2), PALB2 (n=1), CHEK2 (n=1), NBN (n=1), and RAD51D (n=1). VUS also included other cancer syndrome-related genes, such as MLH1 (n=2), MUTYH (n=2), APC (n=1), and RET (n=1). Conclusion: Multigene panel tests in our institute revealed pathogenic/likely pathogenic variants in 24.3% of individuals who suspected hereditary breast cancer. As expected, multigene panel tests also revealed more VUS than pathogenic variants and 40.5% individuals were detected with VUS, which included many genes associated with hereditary breast cancer and other cancer syndromes, in addition to BRCA1 and BRCA2. Individuals with VUS will need to cope with new information if the interpretation of the variant changes in the future. We need to be aware of the characteristics and limitations of this type of panel testing, and to properly utilize the test results and information obtained for good quality patient care.
Citation Format: Yusa Atake, Masayuki Nagahashi, Haruka Kanaoka, Akira Hattori, Ayako Bun, Reiko Fukui, Hiromi Ozawa, Yukie Fujimoto, Tomoko Higuchi, Michiko Imamura, Keiko Murase, Yuichi Takatsuka, Mina Kashima, Chiho Okada, Chinatsu Kinjo, Mikako Miyata, Ayako Miyazaki, Mako Ueda, Hiroshi Tsubamoto, Hideaki Sawai, Yasuo Miyoshi. Germline variants detected by next-generation sequencing-based multigene panel testing in patients with suspected hereditary breast cancer at a University Hospital in Japan [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr P5-12-02.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Yasuo Miyoshi
- 21Dept of Surgery, Division of Breast and Endocrine Surgery, Hyogo Medical University, Nishinomiya-hama, Hyogo, Japan
| |
Collapse
|
4
|
Seto Y, Kittaka N, Taniguchi A, Kanaoka H, Nakajima S, Oyama Y, Kusama H, Watanabe N, Matsui S, Nishio M, Fujisawa F, Takano K, Arita H, Nakayama T. Pegfilgrastim-induced vasculitis of the subclavian and basilar artery complicated by subarachnoid hemorrhage in a breast cancer patient: a case report and review of the literature. Surg Case Rep 2022; 8:155. [PMID: 35960391 PMCID: PMC9374851 DOI: 10.1186/s40792-022-01499-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2022] [Accepted: 07/19/2022] [Indexed: 11/10/2022] Open
Abstract
Abstract
Background
Pegfilgrastim (PEG) is a sustained-duration pegylated form of filgrastim, a granulocyte-colony stimulating factor agent that is widely used as prophylaxis against febrile neutropenia during chemotherapy. We report the case of a breast cancer patient who developed PEG-induced vasculitis complicated by subarachnoid hemorrhage (SAH) and review the relevant literature.
Case presentation
A 48-year-old woman had undergone surgery for breast cancer and was receiving docetaxel and cyclophosphamide as adjuvant chemotherapy (docetaxel 75 mg/m2, cyclophosphamide 600 mg/m2); on day 4 of treatment, PEG had been administered. On day 14, she was admitted to hospital with fever, general malaise, and neck pain, and her C-reactive protein level was found to be high (12.65 mg/dL). Although infection was initially suspected, antimicrobial treatment was ineffective and other laboratory test results were negative for this. Contrast-enhanced computed tomography on day 22 showed thickened vessel walls in the left subclavian artery, the origin of the common carotid artery, and the thoracoabdominal aorta. On day 26, magnetic resonance imaging of the head to investigate possible causes of headache showed signs consistent with SAH, and magnetic resonance angiography images showed irregularity in the basilar artery wall; the findings of both studies were considered to be due to PEG-induced vasculitis. Once treatment with prednisolone 40 mg/day had started, the wall thickening and irregularity improved.
Conclusion
Although an uncommon adverse effect, vasculitis affecting vessels of various sizes may be caused by PEG. To the best of our knowledge, this report is the first to describe a case of G-CSF-induced vasculitis complicated by SAH. In cases of persistent high fever and elevated inflammatory response after PEG administration and in the absence of infection, clinicians should consider the possibility of drug-induced vasculitis.
Collapse
|
5
|
Kanaoka H, Nagahashi M, Ishikawa E, Bun A, Fukui R, Ozawa H, Higuchi T, Natori K, Imamura M, Takatsuka Y, Miyoshi Y. Abstract P4-07-26: Clinical impact of tumor infiltrating lymphocytes and neutrophil-lymphocyte ratio in estrogen receptor-positive/HER2-negative breast cancer patients with high 21-gene signature recurrence scores. Cancer Res 2022. [DOI: 10.1158/1538-7445.sabcs21-p4-07-26] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Many guidelines recommended multi-gene assays to determine an indication of postoperative chemotherapy for estrogen receptor-positive (ER+)/HER2-negative (HER2−) breast cancer patients. The 21-gene signature assay (Oncotype DX) is one such multi-gene assay and is recommended by the National Comprehensive Cancer Network (NCCN) Guidelines for Breast Cancer. The TAILORx trial determined that chemotherapy was indicated for patients with a high risk of recurrence score (high RS; ≧26) on the 21-gene signature assay. Although chemotherapy improves the prognosis of patients in the high-RS group, there is a subgroup of these patients who relapse after chemotherapy. It is expected that survival of this subgroup would improve with additional treatment, such as with CDK4/6 inhibitors. However, factors that predict relapse after chemotherapy in the high-risk patients are unknown. The aim of this study was to identify clinical factors that might predict relapse in the high-RS patients who underwent postoperative chemotherapy. To this end, we focused on tumor infiltrating lymphocytes (TILs) and neutrophil-lymphocyte ratio (NLR) in peripheral blood, and whether these factors are useful in predicting prognosis. Methods: A retrospective analysis of 48 patients who had the 21-gene signature assay performed postoperatively in our institute was performed. Of the 48 patients, 38 were in the low-RS group (1-25), and 10 were in the high-RS group (≧ 26). The cutoff values for TILs and NLR were set to 10% and 2.72, respectively, and the correlations with disease-free survival (DFS) were examined. Results: During the follow-up period (median, 1614 days), six out of 48 patients had distant metastases. Of these, four were in the low-RS and two were in the high-RS group. There was a significant correlation between TILs and RS (median and range of RS, 17.5, 6-47, for TILs-low; and 24, 15-66, for TILs-high; p = 0.0032), and TILs were higher in the high-RS group than in others. There was no correlation between NLR and RS (p = 0.215). In the RS-high patients, DFS was marginally (p = 0.0701) and significantly (p = 0.0253) shorter for TILs-low and NLR-high subgroups, respectively. In the high-RS group, none of six patients with high TILs relapsed, and two of four patients with low TILs relapsed. Conclusions: A subgroup of high-RS ER+/HER2− breast cancer patients with low TILs or high NLR may have a poorer prognosis. TILs are known to correlate with the effect of chemotherapy, and chemotherapy may be less effective in the low-TILs group, even with high-RS scores. TILs and NLR may be useful in determining the need for additional treatment in the high-RS group.
Citation Format: Haruka Kanaoka, Masayuki Nagahashi, Eri Ishikawa, Ayako Bun, Reiko Fukui, Hiromi Ozawa, Tomoko Higuchi, Keiko Natori, Michiko Imamura, Yuichi Takatsuka, Yasuo Miyoshi. Clinical impact of tumor infiltrating lymphocytes and neutrophil-lymphocyte ratio in estrogen receptor-positive/HER2-negative breast cancer patients with high 21-gene signature recurrence scores [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr P4-07-26.
Collapse
Affiliation(s)
| | | | | | - Ayako Bun
- Hyogo College of Medicine, Nishinomiya, Japan
| | - Reiko Fukui
- Hyogo College of Medicine, Nishinomiya, Japan
| | | | | | | | | | | | | |
Collapse
|
6
|
Zhang G, Watanabe H, Kondev F, Lane G, Regan P, Söderström PA, Walker P, Kanaoka H, Korkulu Z, Lee P, Liu J, Nishimura S, Wu J, Yagi A, Ahn D, Alharbi T, Baba H, Browne F, Bruce A, Carroll R, Chae K, Dombradi Z, Doornenbal P, Estrade A, Fukuda N, Griffin C, Ideguchi E, Inabe N, Isobe T, Kanaya S, Kojouharov I, Kubo T, Kubono S, Kurz N, Kuti I, Lalkovski S, Lee C, Lee E, Lorusso G, Lotay G, Moon CB, Nishizuka I, Nita C, Odahara A, Patel Z, Phong V, Podolyák Z, Roberts O, Sakurai H, Schaffner H, Shand C, Shimizu Y, Sumikama T, Suzuki H, Takeda H, Terashima S, Vajta Z, Valiente-Dóbon J, Xu Z. β- γ and isomeric decay spectroscopy of 168Dy. EPJ Web Conf 2018. [DOI: 10.1051/epjconf/201817802023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
This contribution will report on the experimental work on the level structure of 168Dy. The experimental data have been taken as part of the EURICA decay spectroscopy campaign at RIBF, RIKEN in November 2014. In the experiment, a 238U primary beam is accelerated up to 345 MeV/u with an average intensity of 12 pnA. The nuclei of interest are produced by in-flight fission of 238U impinging on Be target with a thickness of 5 mm. The excited states of 168Dy have been populated through the decay from a newly identified isomeric state and via the β decay from 168Tb. In this contribution, scientific motivations, experimental procedure and some preliminary results for this study are presented.
Collapse
|
7
|
Wu J, Nishimura S, Lorusso G, Möller P, Ideguchi E, Regan PH, Simpson GS, Söderström PA, Walker PM, Watanabe H, Xu ZY, Baba H, Browne F, Daido R, Doornenbal P, Fang YF, Gey G, Isobe T, Lee PS, Liu JJ, Li Z, Korkulu Z, Patel Z, Phong V, Rice S, Sakurai H, Sinclair L, Sumikama T, Tanaka M, Yagi A, Ye YL, Yokoyama R, Zhang GX, Alharbi T, Aoi N, Bello Garrote FL, Benzoni G, Bruce AM, Carroll RJ, Chae KY, Dombradi Z, Estrade A, Gottardo A, Griffin CJ, Kanaoka H, Kojouharov I, Kondev FG, Kubono S, Kurz N, Kuti I, Lalkovski S, Lane GJ, Lee EJ, Lokotko T, Lotay G, Moon CB, Nishibata H, Nishizuka I, Nita CR, Odahara A, Podolyák Z, Roberts OJ, Schaffner H, Shand C, Taprogge J, Terashima S, Vajta Z, Yoshida S. 94 β-Decay Half-Lives of Neutron-Rich _{55}Cs to _{67}Ho: Experimental Feedback and Evaluation of the r-Process Rare-Earth Peak Formation. Phys Rev Lett 2017; 118:072701. [PMID: 28256889 DOI: 10.1103/physrevlett.118.072701] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/29/2016] [Indexed: 06/06/2023]
Abstract
The β-decay half-lives of 94 neutron-rich nuclei ^{144-151}Cs, ^{146-154}Ba, ^{148-156}La, ^{150-158}Ce, ^{153-160}Pr, ^{156-162}Nd, ^{159-163}Pm, ^{160-166}Sm, ^{161-168}Eu, ^{165-170}Gd, ^{166-172}Tb, ^{169-173}Dy, ^{172-175}Ho, and two isomeric states ^{174m}Er, ^{172m}Dy were measured at the Radioactive Isotope Beam Factory, providing a new experimental basis to test theoretical models. Strikingly large drops of β-decay half-lives are observed at neutron-number N=97 for _{58}Ce, _{59}Pr, _{60}Nd, and _{62}Sm, and N=105 for _{63}Eu, _{64}Gd, _{65}Tb, and _{66}Dy. Features in the data mirror the interplay between pairing effects and microscopic structure. r-process network calculations performed for a range of mass models and astrophysical conditions show that the 57 half-lives measured for the first time play an important role in shaping the abundance pattern of rare-earth elements in the solar system.
Collapse
Affiliation(s)
- J Wu
- School of Physics and State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing 100871, China
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
| | - S Nishimura
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
| | - G Lorusso
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
- National Physical Laboratory, NPL, Teddington, Middlesex TW11 0LW, United Kingdom
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - P Möller
- Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - E Ideguchi
- Research Center for Nuclear Physics (RCNP), Osaka University, Ibaraki, Osaka 567-0047, Japan
| | - P-H Regan
- National Physical Laboratory, NPL, Teddington, Middlesex TW11 0LW, United Kingdom
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - G S Simpson
- LPSC, Universite Joseph Fourier Grenoble 1, CNRS/IN2P3, Institut National Polytechnique de Grenoble, F-38026 Grenoble Cedex, France
- School of Engineering, University of the West of Scotland, Paisley, PA1 2BE, United Kingdom
- Scottish Universities Physics Alliance, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - P-A Söderström
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
| | - P M Walker
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - H Watanabe
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
- IRCNPC, School of Physics and Nuclear Energy Engineering, Beihang University, Beijing 100191, China
| | - Z Y Xu
- Department of Physics, the University of Hong Kong, Pokfulam Road, Hong Kong
- Department of Physics, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - H Baba
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
| | - F Browne
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
- School of Computing Engineering and Mathematics, University of Brighton, Brighton, BN2 4GJ, United Kingdom
| | - R Daido
- Department of Physics, Osaka University, Machikaneyama-machi 1-1, Osaka 560-0043 Toyonaka, Japan
| | - P Doornenbal
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
| | - Y F Fang
- Department of Physics, Osaka University, Machikaneyama-machi 1-1, Osaka 560-0043 Toyonaka, Japan
| | - G Gey
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
- LPSC, Universite Joseph Fourier Grenoble 1, CNRS/IN2P3, Institut National Polytechnique de Grenoble, F-38026 Grenoble Cedex, France
- Institut Laue-Langevin, B.P. 156, F-38042 Grenoble Cedex 9, France
| | - T Isobe
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
| | - P S Lee
- Department of Physics, Chung-Ang University, Seoul 156-756, Republic of Korea
| | - J J Liu
- Department of Physics, the University of Hong Kong, Pokfulam Road, Hong Kong
| | - Z Li
- School of Physics and State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing 100871, China
| | - Z Korkulu
- Institute for Nuclear Research, Hungarian Academy of Sciences, P. O. Box 51, Debrecen, H-4001, Hungary
| | - Z Patel
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - V Phong
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
- Faculty of Physics, VNU Hanoi University of Science, 334 Nguyen Trai, Thanh Xuan, Hanoi, Vietnam
| | - S Rice
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - H Sakurai
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
- Department of Physics, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - L Sinclair
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
- Department of Physics, University of York, Heslington, York, YO10 5DD, United Kingdom
| | - T Sumikama
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
| | - M Tanaka
- Research Center for Nuclear Physics (RCNP), Osaka University, Ibaraki, Osaka 567-0047, Japan
| | - A Yagi
- Department of Physics, Osaka University, Machikaneyama-machi 1-1, Osaka 560-0043 Toyonaka, Japan
| | - Y L Ye
- School of Physics and State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing 100871, China
| | - R Yokoyama
- Center for Nuclear Study (CNS), University of Tokyo, Wako-shi, Saitama 351-0198, Japan
| | - G X Zhang
- IRCNPC, School of Physics and Nuclear Energy Engineering, Beihang University, Beijing 100191, China
| | - T Alharbi
- Department of Physics, College of Science in Zulfi, Almajmaah University, P.O. Box 1712, 11932, Saudi Arabia
| | - N Aoi
- Research Center for Nuclear Physics (RCNP), Osaka University, Ibaraki, Osaka 567-0047, Japan
| | | | - G Benzoni
- INFN, Sezione di Milano, via Celoria 16, I-20133 Milano, Italy
| | - A M Bruce
- School of Computing Engineering and Mathematics, University of Brighton, Brighton, BN2 4GJ, United Kingdom
| | - R J Carroll
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - K Y Chae
- Department of Physics, Sungkyunkwan University, Suwon 440-746, Republic of Korea
| | - Z Dombradi
- Institute for Nuclear Research, Hungarian Academy of Sciences, P. O. Box 51, Debrecen, H-4001, Hungary
| | - A Estrade
- School of Physics and Astronomy, University of Edinburgh, Edinburgh EH9 3JZ, United Kingdom
| | - A Gottardo
- Dipartimento di Fisica dellUniversit' degli Studi di Padova, I-35131 Padova, Italy
- INFN, Laboratori Nazionali di Legnaro, Legnaro I-35020, Italy
| | - C J Griffin
- School of Physics and Astronomy, University of Edinburgh, Edinburgh EH9 3JZ, United Kingdom
| | - H Kanaoka
- Department of Physics, Osaka University, Machikaneyama-machi 1-1, Osaka 560-0043 Toyonaka, Japan
| | - I Kojouharov
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - F G Kondev
- Nuclear Engineering Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Kubono
- RIKEN Nishina Center, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
| | - N Kurz
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - I Kuti
- Institute for Nuclear Research, Hungarian Academy of Sciences, P. O. Box 51, Debrecen, H-4001, Hungary
| | - S Lalkovski
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - G J Lane
- Department of Nuclear Physics, R.S.P.E., Australian National University, Canberra, A.C.T. 0200, Australia
| | - E J Lee
- Department of Physics, Sungkyunkwan University, Suwon 440-746, Republic of Korea
| | - T Lokotko
- Department of Physics, the University of Hong Kong, Pokfulam Road, Hong Kong
| | - G Lotay
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - C-B Moon
- Hoseo University, Asan, Chungnam 336-795, Korea
| | - H Nishibata
- Department of Physics, Osaka University, Machikaneyama-machi 1-1, Osaka 560-0043 Toyonaka, Japan
| | - I Nishizuka
- Department of Physics, Tohoku University, Aoba, Sendai, Miyagi 980-8578, Japan
| | - C R Nita
- School of Computing Engineering and Mathematics, University of Brighton, Brighton, BN2 4GJ, United Kingdom
- Horia Hulubei National Institute of Physics and Nuclear Engineering (IFIN-HH), RO-077125 Bucharest, Romania
| | - A Odahara
- Department of Physics, Osaka University, Machikaneyama-machi 1-1, Osaka 560-0043 Toyonaka, Japan
| | - Zs Podolyák
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - O J Roberts
- School of Physics, University College Dublin, Belfield, Dublin 4, Ireland
| | - H Schaffner
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - C Shand
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - J Taprogge
- Departamento de Fsica Teórica, Universidad Autónoma de Madrid, E-28049 Madrid, Spain
- Instituto de Estructura de la Materia, CSIC, E-28006 Madrid, Spain
| | - S Terashima
- IRCNPC, School of Physics and Nuclear Energy Engineering, Beihang University, Beijing 100191, China
| | - Z Vajta
- Institute for Nuclear Research, Hungarian Academy of Sciences, P. O. Box 51, Debrecen, H-4001, Hungary
| | - S Yoshida
- Department of Physics, Osaka University, Machikaneyama-machi 1-1, Osaka 560-0043 Toyonaka, Japan
| |
Collapse
|
8
|
Gurgi L, Regan P, Söderström PA, Watanabe H, Walker P, Podolyák Z, Nishimura S, Berry T, Doornenbal P, Lorusso G, Isobe T, Baba H, Xu Z, Sakurai H, Sumikama T, Catford W, Bruce A, Browne F, Lane G, Kondev F, Odahara A, Wu J, Liu H, Xu F, Korkulu Z, Lee P, Liu J, Phong V, Yagi A, Zhang G, Alharbi T, Carroll R, Chae K, Dombradi Z, Estrade A, Fukuda N, Griffin C, Ideguchi E, Inabe N, Kanaoka H, Kojouharov I, Kubo T, Kubono S, Kurz N, Kuti I, Lalkovski S, Lee E, Lee C, Lotay G, Moon C, Nishizuka I, Nita C, Patel Z, Roberts O, Schaffner H, Shand C, Suzuki H, Takeda H, Terashima S, Vajta Z, Kanaya S, Valiente-Dobòn J. Isomer-delayed gamma-ray spectroscopy of neutron-rich 166Tb. EPJ Web Conf 2017. [DOI: 10.1051/epjconf/201714610009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
9
|
Kojima K, Takeuchi T, Kanaoka H, Nakajo T, Kanemasa K, Shimamoto K, Goto H, Okanoue T, Kashima K, Tanaka K. [A young female case of primary sclerosing cholangitis received liver transplantation]. Nihon Shokakibyo Gakkai Zasshi 1999; 96:53-8. [PMID: 10047694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
Affiliation(s)
- K Kojima
- Department of Internal Medicine, National Health Insurance Notogawa Hospital
| | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Nakamura Y, Takeuchi T, Kanaoka H, Okanoue T, Kashima K. [A case of nodular regenerative hyperplasia of liver with idiopathic hypereosinophilic syndrome]. Nihon Shokakibyo Gakkai Zasshi 1997; 94:44-8. [PMID: 9028143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- Y Nakamura
- Department of Internal Medicine, National Health Insurance Notogawa Hospital
| | | | | | | | | |
Collapse
|
11
|
Harada T, Kanaoka H, Kingetsu A, Yoshimura Y. Effects of biscoclaurin alkaloid on superoxide anion generation by peripheral blood and/or salivary neutrophils in various diseases of the oral mucosa. Int J Oral Maxillofac Surg 1997. [DOI: 10.1016/s0901-5027(97)81594-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
12
|
Okanoue T, Sakamoto S, Yasui K, Takami S, Enjo F, Kashima K, Nakagawa Y, Tada H, Kanaoka H, Ohta M. [Side effects of interferon on endocrine and respiratory system in 545 cases of chronic hepatitis C]. Nihon Shokakibyo Gakkai Zasshi 1994; 91:995-1002. [PMID: 7515124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
We investigated the side effects of interferon (IFN) on the endocrine and respiratory system in 545 cases of chronic hepatitis C. Eleven of 494 (2.2%) patients with chronic hepatitis C who were treated with natural or recombinant interferon (IFN) developed thyroid disease while on treatment. Eight patients developed hyperthyroidism and 3 patients developed hypothyroidism. All 11 patients required definitive therapy, who became euthyroid after the therapy. Two patients received nIFN alpha and one patient received rIFN alpha 2b developed diabetes mellitus. Two patients received rIFN alpha 2a and rIFN alpha 2b, respectively, developed interstitial pneumonia 12 weeks and 24 weeks later, respectively. One patient showed positive reaction for RA test and LE factor and positive LE cell, and complained of fever, arthralgia and dry cough. These phenomenon disappeared after the cessation of IFN therapy.
Collapse
Affiliation(s)
- T Okanoue
- Third Department of Internal Medicine, Kyoto Prefectural University of Medicine
| | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Ono M, Hironaka T, Sato S, Hori K, Okanoue T, Kanaoka H. [A case of Budd-Chiari syndrome treated by radical operation under hepatic perfusion and extracorporeal circulation]. Nihon Geka Gakkai Zasshi 1994; 95:282-5. [PMID: 8196595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
A 41-year-old male patient of Budd-Chiari syndrome associated with membranous obstructions of the retrohepatic inferior vena cava and the left hepatic vein was reported. A radical operation was carried out. The retrohepatic inferior vena cava was reconstructed by a ringed EPTFE patch graft after endovenectomy with the aid of extracorporeal circulation for caval and portal bypasses utilizing cold hepatic perfusion. The patient has been doing well 18 months after the operation.
Collapse
Affiliation(s)
- M Ono
- Department of surgery, Kohoku General Hospital, Shiga, Japan
| | | | | | | | | | | |
Collapse
|
14
|
Mori T, Okanoue T, Kanaoka H, Sawa Y, Kashima K. Experimental study of the reversibility of sinusoidal capillarization. Alcohol Alcohol Suppl 1994; 29:67-74. [PMID: 9063822] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
This study investigated the reversibility of sinusoidal capillarization in fibrotic rat liver induced by thioacetamide (TAA; 200 mg/kg body weight three times a week). Six weeks later, collagen fibers and hepatic lobular disarrangement were observed on light microscopy and basement membrane formation was noted in the space of Disse. Sinusoidal endothelial fenestrations (SEFs) were decreased in size and number (defenestration), and factor VIII-related antigen was observed in the cytoplasm. We also clarified the phenotypic reversibility of the sinusoidal endothelial cells. After 4 months following discontinuation of TAA exposure, the diameters and numbers of SEFs were increased. Six months later, the basement membrane in the space of Disse disappeared (as assessed by electron microscopy) and 12 months later, factor VIII-related antigen also disappeared. These results indicate that phenotypical changes in the sinusoidal endothelial cells and sinusoidal capillarization in hepatic fibrosis may be reversed.
Collapse
Affiliation(s)
- T Mori
- Third Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Japan
| | | | | | | | | |
Collapse
|
15
|
Shigematsu Y, Kikawa Y, Sudo M, Kanaoka H, Fujioka M, Dan M. Prenatal diagnosis of isovaleric acidemia by fast atom bombardment and tandem mass spectrometry. Clin Chim Acta 1991; 203:369-74. [PMID: 1777996 DOI: 10.1016/0009-8981(91)90310-9] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- Y Shigematsu
- Department of Pediatrics, Fukui Medical School, Japan
| | | | | | | | | | | |
Collapse
|
16
|
Mikawa H, Mayumi M, Akiyama Y, Ito S, Watanabe Y, Kanaoka H, Takeshita S, Takahashi Y, Akiyama F, Yoshimura T. [Clinical studies on cefixime in pediatrics]. Jpn J Antibiot 1989; 42:2527-39. [PMID: 2693753] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Clinical usefulness of cefixime (CFIX), a new oral cephalosporin antibiotic, in pediatric field was investigated. The results obtained were summarized as follows. 1. The clinical efficacy of CFIX was investigated in a total of 138 children including 49 with upper respiratory tract infections (RTI), 22 with acute bronchitis, 18 with pneumonia, 19 with scarlet fever and 21 with urinary tract infections (UTI). 2. Clinical effectiveness was excellent in 58, good in 60, fair in 14 and poor in 3, with an overall efficacy rate of 87.4%. The efficacy rate classified according to types of infection were 85.7% in upper RTI, 89.5% in acute bronchitis, 94.4% in pneumonia, 78.9% in scarlet fever, and 90.5% in UTI. 3. Out of the suspected causative organisms, 43 strains of a total of 50 strains isolated were eradicated. The bacteriological eradication rate was 86.0%. (Haemophilus influenzae 100%, Haemophilus parainfluenzae 100%, Streptococcus pyogenes 88.5%, Escherichia coli 85.7%). 4. One hundred forty four children were analyzed for side effect. Side effects were observed in 2 children (1.4%) with diarrhea in 1 and anorexia in another. Abnormal laboratory test results were recorded in 4 children (3.3%). The above results suggest that CFIX is a very useful new oral cephalosporin for the treatment of bacterial infections in children.
Collapse
Affiliation(s)
- H Mikawa
- Department of Pediatrics, Kyoto University Hospital
| | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Kachi K, Okanoue T, Morioka H, Ohta M, Ohta Y, Kanaoka H, Sawa Y, Morimoto M. Immunoelectron microscopic localization of actin in normal and cholestatic rat hepatocytes. Gastroenterol Jpn 1989; 24:523-7. [PMID: 2680743 DOI: 10.1007/bf02773879] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
The immunoelectron microscopic localization of actin in hepatocytes was studied in normal, common bile duct-ligated, and phalloidin treated rats. We used the low temperature embedding procedure with Lowicryl K4M and protein A-gold technique was applied to demonstrate the localization of actin. The tissues embedded in Lowicryl K4M at low temperature provided good preservation of ultrastructure and antigenicity of actin. In control rats bile canaliculi were clearly visualized and most of the gold particles were observed on the bile canalicular microvilli, at the pericanalicular ectoplasm, at the cell border, and on the sinusoidal microvilli. In common bile duct-ligated rats and phalloidin treated rats, pericanalicular ectoplasm was thickened and many gold particles were seen there.
Collapse
Affiliation(s)
- K Kachi
- Third Department of Internal Medicine, Kyoto Prefectural University of Medicine, Japan
| | | | | | | | | | | | | | | |
Collapse
|
18
|
Okanoue T, Ohta M, Kachi K, Ohta Y, Sawa Y, Kanaoka H, Kagawa K, Takino T, French SW. Intermediate filaments of hepatocytes and biliary epithelial cells in bile duct obstruction: transmission and scanning electron microscopy study. Gastroenterol Jpn 1988; 23:428-34. [PMID: 3181668 DOI: 10.1007/bf02779212] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
The cytoskeletons of hepatocytes and biliary epithelial cells in bile duct ligated rate livers were investigated by transmission and scanning electron microscopy. The three dimensional organization of the intermediate filaments (IFs) of hepatocytes and biliary epithelial cells was clearly demonstrated by scanning electron microscopy. Cell borders and dilated bile canaliculi were well preserved after perfusion with detergent solution. A very dense filamentous network of IFs was seen throughout the cytoplasm, especially around the dilated bile canaliculi and at the cell borders. IFs in biliary epithelial cells were more numerous compared with hepatocytes. Morphometric analysis showed that the IFs of hepatocytes significantly (p greater than 0.001) increased in amount in bile duct ligated rats. The IFs of biliary epithelial cells showed no significant changes in bile duct ligated rats compared to controls. These results suggest that the increase in IFs in hepatocytes results from the adaptation of the hepatocytes to the stress imposed by bile duct ligation. It may be that the resulting intracanalicular pressure and back diffusion of bile induces a metaplastic change in hepatocytes so that they acquire more IFs to function like the bile duct epithelium to conduct bile flow.
Collapse
Affiliation(s)
- T Okanoue
- Third Department of Internal Medicine, Kyoto Prefectural University of Medicine, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Kanaoka H, Okanoue T, Sawa Y, Ohta Y, Kachi K, Morimoto M, Kagawa K, Takino T. [Morphometric analysis of sinusoidal endothelial fenestration of human liver tissues obtained by blind biopsy]. Nihon Shokakibyo Gakkai Zasshi 1988; 85:1518-24. [PMID: 3184520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
20
|
Abstract
Portions of eight human livers taken by wedge biopsy or needle biopsy were extracted with 0.5% Triton X-100 and then studied by scanning electron microscopy and immunoelectron microscopy. The wedge-biopsy specimens were perfused with the detergent solution. Needle-biopsy specimens were quickly frozen and cracked and then the cracked tissue was immersed in the detergent solution. The three-dimensional filament network of hepatocytes was visualized. A dense network which consisted of intermediate filaments and microfilaments was observed within the cytoplasm of hepatocytes. These filaments were better preserved in the needle biopsies which were quick-frozen and cracked before extraction than in the wedge biopsies. Variation in the amount of the cytoskeletal filaments was less prominent in the hepatocytes treated by rapid freezing. It is concluded that freeze-cracking is the most favorable method for the study of cytoskeletal pathology in various liver diseases in man.
Collapse
Affiliation(s)
- T Okanoue
- Third Department of Internal Medicine, Kyoto Prefectural University of Medicine, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Sawa Y, Okanoue T, Kanaoka H, Kachi K, Ohta Y, Morimoto M, Kagawa K, Yuki T, Takino T, Abe Y. [Pathogenesis of portal hypertension in alcoholic liver disease]. Nihon Shokakibyo Gakkai Zasshi 1988; 85:863-70. [PMID: 3404750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
22
|
Inoue H, Kanaoka H, Ko Y. [Sociocultural aspects of death and dying in Japan]. Kango Tenbo 1985; 10:871-81. [PMID: 3850249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
23
|
Nakao Y, Tsuruzawa M, Kanaoka H, Tanioka K, Sudo M. [Cushing's syndrome caused by ACTH-producing carcinoid tumor originating in the duodenum]. Horumon To Rinsho 1975; 23:603-7. [PMID: 168020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|